JP7630444B2 - Ｘｐｏ１阻害剤の調製プロセス及びｘｐｏ１阻害剤の調製に用いられる中間体 - Google Patents

Ｘｐｏ１阻害剤の調製プロセス及びｘｐｏ１阻害剤の調製に用いられる中間体 Download PDF

Info

Publication number
JP7630444B2
JP7630444B2 JP2021564434A JP2021564434A JP7630444B2 JP 7630444 B2 JP7630444 B2 JP 7630444B2 JP 2021564434 A JP2021564434 A JP 2021564434A JP 2021564434 A JP2021564434 A JP 2021564434A JP 7630444 B2 JP7630444 B2 JP 7630444B2
Authority
JP
Japan
Prior art keywords
compound represented
structural formula
formula
amount
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2021564434A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022531576A (ja
JP2022531576A5 (cg-RX-API-DMAC7.html
Inventor
クリントン オースタッド，ブライアン
ロー，デービッド，ジー．
Original Assignee
カリオファーム セラピューティクス，インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by カリオファーム セラピューティクス，インコーポレイテッド filed Critical カリオファーム セラピューティクス，インコーポレイテッド
Publication of JP2022531576A publication Critical patent/JP2022531576A/ja
Publication of JP2022531576A5 publication Critical patent/JP2022531576A5/ja
Priority to JP2025016855A priority Critical patent/JP7850834B2/ja
Application granted granted Critical
Publication of JP7630444B2 publication Critical patent/JP7630444B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP2021564434A 2019-05-01 2020-05-01 Ｘｐｏ１阻害剤の調製プロセス及びｘｐｏ１阻害剤の調製に用いられる中間体 Active JP7630444B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025016855A JP7850834B2 (ja) 2019-05-01 2025-02-04 Ｘｐｏ１阻害剤の調製プロセス及びｘｐｏ１阻害剤の調製に用いられる中間体

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962841649P 2019-05-01 2019-05-01
US62/841,649 2019-05-01
PCT/US2020/031124 WO2020223678A1 (en) 2019-05-01 2020-05-01 Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xp01 inhibitors

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025016855A Division JP7850834B2 (ja) 2019-05-01 2025-02-04 Ｘｐｏ１阻害剤の調製プロセス及びｘｐｏ１阻害剤の調製に用いられる中間体

Publications (3)

Publication Number Publication Date
JP2022531576A JP2022531576A (ja) 2022-07-07
JP2022531576A5 JP2022531576A5 (cg-RX-API-DMAC7.html) 2023-04-20
JP7630444B2 true JP7630444B2 (ja) 2025-02-17

Family

ID=70802955

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021564434A Active JP7630444B2 (ja) 2019-05-01 2020-05-01 Ｘｐｏ１阻害剤の調製プロセス及びｘｐｏ１阻害剤の調製に用いられる中間体
JP2025016855A Active JP7850834B2 (ja) 2019-05-01 2025-02-04 Ｘｐｏ１阻害剤の調製プロセス及びｘｐｏ１阻害剤の調製に用いられる中間体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025016855A Active JP7850834B2 (ja) 2019-05-01 2025-02-04 Ｘｐｏ１阻害剤の調製プロセス及びｘｐｏ１阻害剤の調製に用いられる中間体

Country Status (14)

Country Link
US (1) US12479806B2 (cg-RX-API-DMAC7.html)
EP (1) EP3962898A1 (cg-RX-API-DMAC7.html)
JP (2) JP7630444B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220004142A (cg-RX-API-DMAC7.html)
CN (1) CN114040909B (cg-RX-API-DMAC7.html)
AU (1) AU2020266170B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021021706A2 (cg-RX-API-DMAC7.html)
CA (1) CA3135712A1 (cg-RX-API-DMAC7.html)
CR (1) CR20210590A (cg-RX-API-DMAC7.html)
IL (1) IL287673B1 (cg-RX-API-DMAC7.html)
MA (1) MA55808A (cg-RX-API-DMAC7.html)
MX (1) MX2021013211A (cg-RX-API-DMAC7.html)
SG (1) SG11202111993SA (cg-RX-API-DMAC7.html)
WO (1) WO2020223678A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114040909B (zh) 2019-05-01 2025-06-03 卡尔约药物治疗公司 用于制备xpo1抑制剂以及用于制备xp01抑制剂的中间体的方法
JP2021048976A (ja) * 2019-09-24 2021-04-01 株式会社ユニバーサルエンターテインメント 遊技機
CN112679477B (zh) * 2020-12-17 2021-10-26 佛山奕安赛医药科技有限公司 塞利尼索及其中间体的制备方法
CN116514773B (zh) * 2023-04-24 2024-12-03 重庆汉佩生物科技有限公司 一种Verdinexor(KPT-335)及其盐酸盐的合成方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014521652A (ja) 2011-07-29 2014-08-28 カリオファーム セラピューティクス，インコーポレイテッド ヒドラジド含有核輸送調節因子およびその使用
WO2014205393A1 (en) 2013-06-21 2014-12-24 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
JP2015516434A (ja) 2012-05-09 2015-06-11 カリオファーム セラピューティクス，インコーポレイテッド 核内輸送調節因子およびその使用
WO2017118940A1 (en) 2016-01-08 2017-07-13 Dr. Reddy's Laboratories Limited Solid forms of selinexor and process for their preparation
JP2017527549A (ja) 2014-08-15 2017-09-21 カリオファーム セラピューティクス，インコーポレイテッド セリネクソールの多形体
WO2018129227A1 (en) 2017-01-05 2018-07-12 Watson Laboratories Inc. Novel crystalline forms of selinexor and process for their preparation

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2542089B1 (en) 2010-03-05 2017-01-18 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
EP2665362B1 (en) 2011-01-17 2016-03-30 Karyopharm Therapeutics, Inc. Olefin containing nuclear transport modulators and uses thereof
JP6006794B2 (ja) 2011-07-29 2016-10-12 カリオファーム セラピューティクス，インコーポレイテッド 核内輸送調節因子およびその使用
EP2968278B8 (en) 2013-03-15 2019-05-22 Karyopharm Therapeutics Inc. Methods of promoting wound healing using crm1 inhibitors
ME03421B (me) 2013-06-21 2020-01-20 Karyopharm Therapeutics Inc 1,2,4-triazoli kao modulatori nuklearnog transporta i njihova upotreba
US10526295B2 (en) 2015-12-31 2020-01-07 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
EP3397634A1 (en) 2015-12-31 2018-11-07 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
CN114040909B (zh) 2019-05-01 2025-06-03 卡尔约药物治疗公司 用于制备xpo1抑制剂以及用于制备xp01抑制剂的中间体的方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2014521652A (ja) 2011-07-29 2014-08-28 カリオファーム セラピューティクス，インコーポレイテッド ヒドラジド含有核輸送調節因子およびその使用
JP2015516434A (ja) 2012-05-09 2015-06-11 カリオファーム セラピューティクス，インコーポレイテッド 核内輸送調節因子およびその使用
WO2014205393A1 (en) 2013-06-21 2014-12-24 Karyopharm Therapeutics Inc. Nuclear transport modulators and uses thereof
JP2017527549A (ja) 2014-08-15 2017-09-21 カリオファーム セラピューティクス，インコーポレイテッド セリネクソールの多形体
WO2017118940A1 (en) 2016-01-08 2017-07-13 Dr. Reddy's Laboratories Limited Solid forms of selinexor and process for their preparation
WO2018129227A1 (en) 2017-01-05 2018-07-12 Watson Laboratories Inc. Novel crystalline forms of selinexor and process for their preparation

Also Published As

Publication number Publication date
AU2020266170A1 (en) 2021-11-25
US20220242832A1 (en) 2022-08-04
CR20210590A (es) 2022-03-11
JP2025072490A (ja) 2025-05-09
JP2022531576A (ja) 2022-07-07
JP7850834B2 (ja) 2026-04-23
CA3135712A1 (en) 2020-11-05
WO2020223678A1 (en) 2020-11-05
US12479806B2 (en) 2025-11-25
MX2021013211A (es) 2022-03-11
SG11202111993SA (en) 2021-11-29
IL287673B1 (en) 2026-01-01
EP3962898A1 (en) 2022-03-09
MA55808A (fr) 2022-03-09
CN114040909A (zh) 2022-02-11
IL287673A (en) 2021-12-01
BR112021021706A2 (pt) 2022-04-19
KR20220004142A (ko) 2022-01-11
AU2020266170B2 (en) 2026-02-26
CN114040909B (zh) 2025-06-03

Similar Documents

Publication Publication Date Title
JP7850834B2 (ja) Ｘｐｏ１阻害剤の調製プロセス及びｘｐｏ１阻害剤の調製に用いられる中間体
EP3645518B1 (en) Synthesis of omecamtiv mecarbil
JP6985367B2 (ja) 新規化合物および方法
CN117120436A (zh) 一种一步法合成乙内酰硫脲衍生物的方法
CZ292446B6 (cs) Způsob přípravy N,N,6-trimethyl-2-(4-methylfenyl)imidazo[1,2-a]pyridin-3-acetamidu a jeho solí
JP5960243B2 (ja) ２工程での３，５−ジオキソヘキサン酸エステルの製造
JP7406692B2 (ja) 可溶性グアニル酸シクラーゼ刺激薬を調製するための方法
AU2019309693B2 (en) Process for the preparation of bromodomain inhibitor
CN114560862A (zh) 一种吡咯并[1,2-a]喹喔啉-4(5h)-酮及其衍生物的合成方法
CN103328471A (zh) 制备氮杂吲唑衍生物的方法
CN114436991A (zh) 一种2-氨基噻唑类化合物的合成方法
JP2023542365A (ja) タウロデオキシコール酸ナトリウムの大量生産方法
JP4209022B2 (ja) イソシアノ酢酸アルキルエステル類の製造法
CN115368283A (zh) 一种手性结构或非手性结构的顺式-3-氟-4-羟基吡咯烷及其衍生物的制备方法
WO2024110862A9 (en) Process for preparing zanubrutinib
CN115974790A (zh) 一种合成替格瑞洛六元环中间体的方法
JP2026513413A (ja) ４－アミノインダンの製造方法およびジヒドロインデニル－ピラゾロ［３，４－ｂ］ピリジンアミン化合物の製造方法
WO2024251276A1 (zh) 氧代吡啶类化合物的新型制备方法及关键中间体和应用
TW202219027A (zh) 取代的丙烯酸酯化合物的製備
CN110922402A (zh) 一种c-3位碘代中氮茚类化合物及其制备方法
JPH09216886A (ja) トリアゾロピリダジン誘導体の製造法
CN106749175A (zh) 一种曲格列汀的纯化方法
JPWO2000078722A1 (ja) 医薬品中間体化合物の製造方法
JPS6253947A (ja) 〔２−（４−アセトキシ−２−イソプロピル−５−メチルフェノキシ）エチル〕−ジメチルアミン塩酸塩の製造方法
CZ20001012A3 (cs) Imidazopyridinové deriváty a způsob jejich přípravy

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230412

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230412

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240625

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20240919

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20241011

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250107

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250204

R150 Certificate of patent or registration of utility model

Ref document number: 7630444

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150